关于30岁以上慢性乙型肝炎病毒感染育龄期女性的抗病毒治疗和管理的思考  

Antiviral treatment and management of chronic hepatitis B in women of childbearing age above 30 years

作　　者：刘志华[1] LIU Zhihua(Liver Disease Center,Nanfang Hospital,Southern Medical University,Guangzhou,Guangdong 510515,China)

机构地区：[1]南方医科大学南方医院肝病中心,广东广州510515

出　　处：《中国病毒病杂志》2025年第1期33-35,共3页Chinese Journal of Viral Diseases

摘　　要：慢性乙型肝炎病毒(hepatitis B virus,HBV)感染育龄期女性是一个特殊人群,对这一人群的治疗管理,需要考虑母婴双方的获益和安全性。当前,随着扩大抗病毒治疗理念的广为接受,以及《慢性乙型肝炎防治指南(2022年版)》(简称《指南》)的发表,关于这一特殊人群的抗病毒治疗问题,特别是对30岁以上HBV感染育龄期女性的抗病毒治疗,存在一些争议。本文以《指南》为指导原则,结合临床实际,分别从备孕期、妊娠期和产后三个阶段,对30岁以上慢性HBV感染育龄期女性的治疗管理问题进行了分析。The treatment and management for women of childbearing age above 30 years should be considered from the benefits and safety of both mother and infant.At present,with the wide acceptance of the concept of antiviral treatment and the publication of the Guidelines for prevention and treatment of chronic hepatitis B(2022edition),there are some controversies about the antiviral treatment of this special population,especially those over 30 years of age.Based on the 2022 version of guidelines for hepatitis B and the clinical practice,in this article,we analyze the treatment and management of women with chronic HBV infection of childbearing age above 30 years from the three stages of before pregnancy,pregnancy and postpartum.

关 键 词：乙型肝炎 慢性 育龄期女性 抗病毒治疗 管理 

分 类 号：R512.62[医药卫生—内科学]